S. Baasner

发表

Development of AEZS-115 (ZEN-019) by optimization of structurally unique, orally active, peptidomimetic GnRH antagonists.

M. Teifel, K. Paulini, S. Baasner, 2009, Advances in experimental medicine and biology.

Synthesis and structure-activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents.

E. Günther, S. Baasner, P. Marchand, 2009, Bioorganic & medicinal chemistry.

Synthesis, antiproliferative activity and inhibition of tubulin polymerization by 1,5- and 1,8-disubstituted 10H-anthracen-9-ones bearing a 10-benzylidene or 10-(2-oxo-2-phenylethylidene) moiety.

S. Baasner, M. Gerlach, P. Schmidt, 2010, European journal of medicinal chemistry.

Differentiated control of deranged nitric oxide metabolism: a therapeutic option in sepsis?

C. Ince, M. Westphal, J. Stover, 2013, Critical Care.

Design and Synthesis of a Focused Library of Novel Aryl‐ and Heteroaryl‐Ketopiperazides

E. Günther, S. Baasner, M. Gerlach, 2004, Archiv der Pharmazie.

Phenylimino-10H-anthracen-9-ones as novel antimicrotubule agents-synthesis, antiproliferative activity and inhibition of tubulin polymerization.

S. Baasner, M. Gerlach, P. Schmidt, 2011, Bioorganic & medicinal chemistry.

Synthetic 2-aroylindole derivatives as a new class of potent tubulin-inhibitory, antimitotic agents.

T. Beckers, H. Fiebig, S. Mahboobi, 2001, Journal of medicinal chemistry.

Bis(1H-2-indolyl)methanones as a novel class of inhibitors of the platelet-derived growth factor receptor kinase.

T. Beckers, C. Schächtele, S. Teller, 2002, Journal of medicinal chemistry.

Side chain modifications of (indol-3-yl)glyoxamides as antitumor agents

S. Baasner, P. Marchand, G. Le Baut, 2008 .

Sulfonate derivatives of naphtho[2,3-b]thiophen-4(9H)-one and 9(10H)-anthracenone as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization.

Peter Schmidt, A. Zuse, Eberhard Unger, 2007, Journal of medicinal chemistry.

Pyrrolo[3,4-c]-beta-carboline-diones as a novel class of inhibitors of the platelet-derived growth factor receptor kinase.

T. Beckers, S. Teller, S. Mahboobi, 2000, European journal of medicinal chemistry.

Manipulation of nitric oxide levels with a modified hydroxyethyl starch molecule

C. Ince, M. Westphal, F. Nocken, 2012, Critical Care.

Switching off HER-2/neu in a tetracycline-controlled mouse tumor model leads to apoptosis and tumor-size-dependent remission.

Thomas Beckers, Jan G Hengstler, Franz Oesch, 2003, Cancer research.

Reversible tumorigenesis in mice by conditional expression of the HER2/c-erbB2 receptor tyrosine kinase.

H. von Melchner, P. Hilgard, T. Klenner, 1996, Oncogene.

Tumor-Size-Dependent Remission Tumor Model Leads to Apoptosis and Switching Off HER-2 / neu in a Tetracycline-Controlled Mouse

F. Oesch, B. Seliger, H. Lehr, 2003 .

Clinical significance and risk factors for new onset and recurring atrial fibrillation following cardiac surgery - a retrospective data analysis

B. Ellger, M. Westphal, J. Stover, 2017, BMC Anesthesiology.

The complex role of nitric oxide under physiologic versus septic conditions

C. Ince, M. Westphal, J. Stover, 2013 .

Manipulation of Nitric Oxide Levels via a Modified Hydroxyethyl Starch Molecule.

C. Ince, U. Aksu, F. Nocken, 2012, Journal of Surgical Research.

Fully Balanced Fluids do not Improve Microvascular Oxygenation, Acidosis and Renal Function in a Rat Model of Endotoxemia

C. Ince, M. Westphal, B. Ergin, 2016, Shock.

Switching off HER-2/neu in a tetracycline-controlled mouse tumor model leads to apoptosis and tumor-size-dependent remission.

J. Hengstler, W. Brenner, S. Gebhard, 2003, Cancer research.